154 Stock Overview
Designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 154 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
InMode Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$15.93 |
| 52 Week High | US$24.76 |
| 52 Week Low | US$13.51 |
| Beta | 2.11 |
| 1 Month Change | -12.71% |
| 3 Month Change | 12.66% |
| 1 Year Change | -17.25% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -55.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| 154 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -1.6% | -1.6% | 0.3% |
| 1Y | -17.2% | -6.5% | 8.4% |
Return vs Industry: 154 underperformed the German Medical Equipment industry which returned -6.5% over the past year.
Return vs Market: 154 underperformed the German Market which returned 8.4% over the past year.
Price Volatility
| 154 volatility | |
|---|---|
| 154 Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 154 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 154's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 581 | Moshe Mizrahy | www.inmodemd.com |
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation.
InMode Ltd. Fundamentals Summary
| 154 fundamental statistics | |
|---|---|
| Market cap | €1.38b |
| Earnings (TTM) | €149.83m |
| Revenue (TTM) | €413.15m |
9.2x
P/E Ratio3.3x
P/S RatioIs 154 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 154 income statement (TTM) | |
|---|---|
| Revenue | US$423.75m |
| Cost of Revenue | US$77.80m |
| Gross Profit | US$345.95m |
| Other Expenses | US$192.28m |
| Earnings | US$153.67m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.82 |
| Gross Margin | 81.64% |
| Net Profit Margin | 36.26% |
| Debt/Equity Ratio | 0% |
How did 154 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 01:30 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
InMode Ltd. is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jeffrey Johnson | Baird |
| Matt Miksic | Barclays |
| Travis Steed | Barclays |